Neo Ivy Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265K | Buy |
+2,907
| New | +$265K | 0.08% | 257 |
|
|
2025
Q1 | – | Sell |
-6,528
| Closed | -$689K | – | 437 |
|
|
2024
Q4 | $689K | Buy |
6,528
+5,144
| +372% | +$543K | 0.14% | 161 |
|
|
2024
Q3 | $150K | Buy |
+1,384
| New | +$150K | 0.05% | 229 |
|
|
2023
Q4 | – | Sell |
-5,712
| Closed | -$641K | – | 475 |
|
|
2023
Q3 | $641K | Buy |
+5,712
| New | +$641K | 0.28% | 117 |
|
|
2022
Q3 | – | Sell |
-1,195
| Closed | -$125K | – | 583 |
|
|
2022
Q2 | $125K | Buy |
+1,195
| New | +$125K | 0.33% | 96 |
|
|
2021
Q4 | – | Sell |
-3,106
| Closed | -$360K | – | 656 |
|
|
2021
Q3 | $360K | Buy |
+3,106
| New | +$360K | 0.41% | 86 |
|
|
2021
Q2 | – | Sell |
-3,118
| Closed | -$485K | – | 635 |
|
|
2021
Q1 | $485K | Buy |
+3,118
| New | +$485K | 0.53% | 53 |
|
|
2020
Q4 | – | Sell |
-1,120
| Closed | -$147K | – | 606 |
|
|
2020
Q3 | $147K | Sell |
1,120
-1,986
| -64% | -$261K | 0.15% | 236 |
|
|
2020
Q2 | $360K | Buy |
+3,106
| New | +$360K | 0.41% | 86 |
|
|
2019
Q3 | – | Sell |
-10,630
| Closed | -$1.22M | – | 414 |
|
|
2019
Q2 | $1.22M | Buy |
+10,630
| New | +$1.22M | 0.68% | 52 |
|